Table 2 Efficacy of imidacloprid 10%/moxidectin 1% spot-on in prevention and treatment of Aelurostrongylus abstrusus infection as determined in three controlled studies
Study | Group | Cats with ≥ 1 worm | Totala/viableb worm burdenc | Efficacy (%) | Adequacy of infection |
|---|---|---|---|---|---|
1 | (1) Control | 8 | 28.8 (11–68)a | na | Yes** |
(2) Advocate® (SD 36) | 7 | 3.4* (0–18)a | 88.3 | na | |
2 | (1) Control | 8 | 14.3 (4–42)b | na | Yes** |
(2) Advocate® SD 10 + SD 18 | 0 | 0*b | 100 | na | |
(3) Advocate® SD 53, 81, 109 | 1 | 0.1* (0–1)b | 99.4 | na | |
3 | (1) Control | 8 | 32.6 (3–86)b | na | Yes** |
(2) Advocate® SD 4 + SD 24 | 0 | 0*b | 100 | na | |
(3) Advocate® SD 10 + SD 18 | 0 | 0*b | 100 | na | |
(4) Advocate® SD 20 + SD 8 | 0 | 0*b | 100 | na |